138 related articles for article (PubMed ID: 30412056)
1. Dual enkephalinase inhibitor PL265: a novel topical treatment to alleviate corneal pain and inflammation.
Reaux-Le Goazigo A; Poras H; Ben-Dhaou C; Ouimet T; Baudouin C; Wurm M; Melik Parsadaniantz S
Pain; 2019 Feb; 160(2):307-321. PubMed ID: 30412056
[TBL] [Abstract][Full Text] [Related]
2. Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain.
González-Rodríguez S; Poras H; Menéndez L; Lastra A; Ouimet T; Fournié-Zaluski MC; Roques BP; Baamonde A
Scand J Pain; 2017 Jan; 14():25-38. PubMed ID: 28850427
[TBL] [Abstract][Full Text] [Related]
3. Ocular inflammation induces trigeminal pain, peripheral and central neuroinflammatory mechanisms.
Launay PS; Reboussin E; Liang H; Kessal K; Godefroy D; Rostene W; Sahel JA; Baudouin C; Melik Parsadaniantz S; Reaux Le Goazigo A
Neurobiol Dis; 2016 Apr; 88():16-28. PubMed ID: 26747211
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment with a mu opioid receptor agonist alleviates corneal allodynia and corneal nerve sensitization in mice.
Joubert F; Guerrero-Moreno A; Fakih D; Reboussin E; Gaveriaux-Ruff C; Acosta MC; Gallar J; Sahel JA; Bodineau L; Baudouin C; Rostène W; Mélik-Parsadaniantz S; Réaux-Le Goazigo A
Biomed Pharmacother; 2020 Dec; 132():110794. PubMed ID: 33035833
[TBL] [Abstract][Full Text] [Related]
5. Chronic dry eye induced corneal hypersensitivity, neuroinflammatory responses, and synaptic plasticity in the mouse trigeminal brainstem.
Fakih D; Zhao Z; Nicolle P; Reboussin E; Joubert F; Luzu J; Labbé A; Rostène W; Baudouin C; Mélik Parsadaniantz S; Réaux-Le Goazigo A
J Neuroinflammation; 2019 Dec; 16(1):268. PubMed ID: 31847868
[TBL] [Abstract][Full Text] [Related]
6. Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain.
Bonnard E; Poras H; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 2016 Oct; 788():176-182. PubMed ID: 27266667
[TBL] [Abstract][Full Text] [Related]
7. Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.
Bonnard E; Poras H; Nadal X; Maldonado R; Fournié-Zaluski MC; Roques BP
Pharmacol Res Perspect; 2015 Mar; 3(2):e00116. PubMed ID: 25692029
[TBL] [Abstract][Full Text] [Related]
8. Ocular surface injury induces inflammation in the brain: in vivo and ex vivo evidence of a corneal-trigeminal axis.
Ferrari G; Bignami F; Giacomini C; Capitolo E; Comi G; Chaabane L; Rama P
Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6289-300. PubMed ID: 25146993
[TBL] [Abstract][Full Text] [Related]
9. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons.
Meunier A; Latrémolière A; Mauborgne A; Bourgoin S; Kayser V; Cesselin F; Hamon M; Pohl M
Mol Ther; 2005 Apr; 11(4):608-16. PubMed ID: 15771963
[TBL] [Abstract][Full Text] [Related]
11. TRPM8: A Therapeutic Target for Neuroinflammatory Symptoms Induced by Severe Dry Eye Disease.
Fakih D; Baudouin C; Réaux-Le Goazigo A; Mélik Parsadaniantz S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228217
[TBL] [Abstract][Full Text] [Related]
12. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
Iwaszkiewicz KS; Hua S
Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
[TBL] [Abstract][Full Text] [Related]
13. Bilobalide, a unique constituent of Ginkgo biloba, inhibits inflammatory pain in rats.
Goldie M; Dolan S
Behav Pharmacol; 2013 Aug; 24(4):298-306. PubMed ID: 23838965
[TBL] [Abstract][Full Text] [Related]
14. Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration.
Bonelli F; Demirsoy I; Lasagni Vitar RM; Fonteyne P; Ferrari G
Ocul Surf; 2023 Oct; 30():92-103. PubMed ID: 37690516
[TBL] [Abstract][Full Text] [Related]
15. Corneal neurotoxicity due to topical benzalkonium chloride.
Sarkar J; Chaudhary S; Namavari A; Ozturk O; Chang JH; Yco L; Sonawane S; Khanolkar V; Hallak J; Jain S
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1792-802. PubMed ID: 22410563
[TBL] [Abstract][Full Text] [Related]
16. Benzalkonium chloride-induced direct and indirect toxicity on corneal epithelial and trigeminal neuronal cells: proinflammatory and apoptotic responses in vitro.
Vitoux MA; Kessal K; Melik Parsadaniantz S; Claret M; Guerin C; Baudouin C; Brignole-Baudouin F; Réaux-Le Goazigo A
Toxicol Lett; 2020 Feb; 319():74-84. PubMed ID: 31707104
[TBL] [Abstract][Full Text] [Related]
17. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.
Tejada MA; Montilla-García A; Cronin SJ; Cikes D; Sánchez-Fernández C; González-Cano R; Ruiz-Cantero MC; Penninger JM; Vela JM; Baeyens JM; Cobos EJ
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8396-8401. PubMed ID: 28716934
[TBL] [Abstract][Full Text] [Related]
18. Synthetic neurotensin analogues are nontoxic analgesics for the rabbit cornea.
Kim C; Barbut D; Heinemann MH; Pasternak G; Rosenblatt MI
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3586-93. PubMed ID: 24825106
[TBL] [Abstract][Full Text] [Related]
19. Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.
Thapa D; Cairns EA; Szczesniak AM; Kulkarni PM; Straiker AJ; Thakur GA; Kelly MEM
Molecules; 2020 Jan; 25(2):. PubMed ID: 31968549
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment.
Bignami F; Lorusso A; Rama P; Ferrari G
Acta Ophthalmol; 2017 Nov; 95(7):e641-e648. PubMed ID: 28205389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
